IFN-γ- and IL-17-producing CD8+ T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity
Background While adoptive transfer of T-cells has been a major medical breakthrough for patients with B cell malignancies, the development of safe and effective T-cell-based immunotherapy for central nervous system (CNS) tumors, such as glioblastoma (GBM), still needs to overcome multiple challenges...
Main Authors: | Takayuki Ohkuri, Akemi Kosaka, Hideho Okada, Maki Ikeura, Andres M Salazar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-06-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/9/6/e002426.full |
Similar Items
-
Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.
by: Edward Sionov, et al.
Published: (2015-08-01) -
Praziquantel facilitates IFN-γ-producing CD8+ T cells (Tc1) and IL-17-producing CD8+ T cells (Tc17) responses to DNA vaccination in mice.
by: Qiang Zou, et al.
Published: (2011-01-01) -
Antifungal Tc17 cells are durable and stable, persisting as long-lasting vaccine memory without plasticity towards IFNγ cells.
by: Som Gowda Nanjappa, et al.
Published: (2017-05-01) -
Peripheral Tc17 and Tc17/Interferon-γ Cells are Increased and Associated with Lung Function in Patients with Chronic Obstructive Pulmonary Disease
by: Wei-Han Xu, et al.
Published: (2016-01-01) -
Alcohol dependence promotes systemic IFN-γ and IL-17 responses in mice.
by: Kayla Frank, et al.
Published: (2020-01-01)